Kimberly Chong

Array ( [id] => 7580988 [patent_doc_number] => 20110294871 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'LIPIDS, LIPID COMPLEXES AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/173296 [patent_app_country] => US [patent_app_date] => 2011-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 20309 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294871.pdf [firstpage_image] =>[orig_patent_app_number] => 13173296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8621313 [patent_doc_number] => 08354224 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-15 [patent_title] => 'MicroRNA fingerprints during human megakaryocytopoiesis' [patent_app_type] => utility [patent_app_number] => 13/169184 [patent_app_country] => US [patent_app_date] => 2011-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 25 [patent_no_of_words] => 26713 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13169184 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9530328 [patent_doc_number] => 08754202 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-17 [patent_title] => 'RNAi-related inhibition of TNFα signaling pathway for treatment of ocular angiogenesis' [patent_app_type] => utility [patent_app_number] => 13/169549 [patent_app_country] => US [patent_app_date] => 2011-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12978 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13169549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7501990 [patent_doc_number] => 20110263686 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/168857 [patent_app_country] => US [patent_app_date] => 2011-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 20183 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13168857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8846452 [patent_doc_number] => 08455634 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-04 [patent_title] => 'Antisense oligonucleotides for inducing exon skipping and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 13/168863 [patent_app_country] => US [patent_app_date] => 2011-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 20734 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13168863 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10912956 [patent_doc_number] => 20140315975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-23 [patent_title] => 'APOPTOSIS-INDUCING AGENT' [patent_app_type] => utility [patent_app_number] => 14/127894 [patent_app_country] => US [patent_app_date] => 2011-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 17178 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14127894 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7776533 [patent_doc_number] => 20120039986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'COMPOSITIONS AND METHODS FOR SIRNA INHIBITION OF ANGIOPOIETIN 1 AND 2 AND THEIR RECEPTOR TIE2' [patent_app_type] => utility [patent_app_number] => 13/163806 [patent_app_country] => US [patent_app_date] => 2011-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13582 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20120039986.pdf [firstpage_image] =>[orig_patent_app_number] => 13163806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8251927 [patent_doc_number] => 20120156246 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-21 [patent_title] => 'REPROGRAMMING CANCER CELLS' [patent_app_type] => utility [patent_app_number] => 13/162558 [patent_app_country] => US [patent_app_date] => 2011-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 21407 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20120156246.pdf [firstpage_image] =>[orig_patent_app_number] => 13162558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7511537 [patent_doc_number] => 20110257247 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'Method of Treating Neurodegenerative Disease' [patent_app_type] => utility [patent_app_number] => 13/161367 [patent_app_country] => US [patent_app_date] => 2011-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 36579 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20110257247.pdf [firstpage_image] =>[orig_patent_app_number] => 13161367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9323338 [patent_doc_number] => 08658356 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-25 [patent_title] => 'Methods and compositions for the specific inhibition of gene expression by double-stranded RNA' [patent_app_type] => utility [patent_app_number] => 13/152686 [patent_app_country] => US [patent_app_date] => 2011-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 35 [patent_no_of_words] => 23123 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 353 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13152686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7696044 [patent_doc_number] => 20110230546 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'dsRNA COMPOSITIONS AND METHODS FOR TREATING HPV INFECTION' [patent_app_type] => utility [patent_app_number] => 13/116947 [patent_app_country] => US [patent_app_date] => 2011-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30914 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0230/20110230546.pdf [firstpage_image] =>[orig_patent_app_number] => 13116947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8791718 [patent_doc_number] => 20130108687 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-02 [patent_title] => 'COMPOSITIONS FOR USE IN TREATING OR DIAGNOSING BONE DISORDERS AND/OR CARDIOVASCULAR DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/699272 [patent_app_country] => US [patent_app_date] => 2011-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 23466 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13699272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7560926 [patent_doc_number] => 20110274758 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'MICROSPHERE-BASED COMPOSITION FOR PREVENTING AND/OR REVERSING NEW-ONSET AUTOIMMUNE DIABETES' [patent_app_type] => utility [patent_app_number] => 13/103433 [patent_app_country] => US [patent_app_date] => 2011-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 5872 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20110274758.pdf [firstpage_image] =>[orig_patent_app_number] => 13103433 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8138739 [patent_doc_number] => 20120093913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'Inhibition of SYK kinase expression' [patent_app_type] => utility [patent_app_number] => 13/067035 [patent_app_country] => US [patent_app_date] => 2011-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5128 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20120093913.pdf [firstpage_image] =>[orig_patent_app_number] => 13067035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9569892 [patent_doc_number] => 20140187605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-03 [patent_title] => 'PROTECTION AGAINST ENDOTHELIAL BARRIER DYSFUNCTION THROUGH INHIBITION OF THE TYROSINE KINASE ABL-RELATED GENE (ARG)' [patent_app_type] => utility [patent_app_number] => 14/115279 [patent_app_country] => US [patent_app_date] => 2011-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11797 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14115279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7657383 [patent_doc_number] => 20110306652 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'COMPOSITIONS AND THEIR USES DIRECTED TO HUNTINGTIN' [patent_app_type] => utility [patent_app_number] => 13/090146 [patent_app_country] => US [patent_app_date] => 2011-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22573 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20110306652.pdf [firstpage_image] =>[orig_patent_app_number] => 13090146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10162752 [patent_doc_number] => 09193969 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-24 [patent_title] => 'Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types' [patent_app_type] => utility [patent_app_number] => 13/066590 [patent_app_country] => US [patent_app_date] => 2011-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 19 [patent_no_of_words] => 49962 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13066590 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9389340 [patent_doc_number] => 08685938 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-01 [patent_title] => 'Methods to enhance T-cell mediated immune response' [patent_app_type] => utility [patent_app_number] => 13/082790 [patent_app_country] => US [patent_app_date] => 2011-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 16168 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13082790 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9958209 [patent_doc_number] => 09006415 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-14 [patent_title] => 'Targeted delivery of nucleic acids' [patent_app_type] => utility [patent_app_number] => 13/081432 [patent_app_country] => US [patent_app_date] => 2011-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 92 [patent_no_of_words] => 21450 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13081432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8653071 [patent_doc_number] => 08372819 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-12 [patent_title] => 'Methods and compositions for targeting skip' [patent_app_type] => utility [patent_app_number] => 13/078813 [patent_app_country] => US [patent_app_date] => 2011-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 21982 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13078813 [rel_patent_id] =>[rel_patent_doc_number] =>)